by andrewmm2007 | Apr 5, 2021 | Press Releases
SAN FRANCISCO, April 5, 2021 – Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit immunosuppressive and cancer-promoting signaling pathways, today announced the forthcoming oral presentation of preclinical data on selective...
by andrewmm2007 | Feb 22, 2021 | Press Releases
SAN FRANCISCO, CA, February 22, 2021 – Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways, today announced the completion of a $30M Series A financing. Thefinancing was...
by andrewmm2007 | Jan 12, 2021 | Press Releases
SAN FRANCISCO, January 12, 2021 – Teon Therapeutics, a private biopharmaceutical company developing a focused portfolio of small molecules that modulate metabolic signaling pathways in the tumor microenvironment, today announced the appointment of Glen Giovannetti, to...
by andrewmm2007 | Dec 14, 2020 | Press Releases
SAN FRANCISCO, December 14, 2020 – Teon Therapeutics, a private biopharmaceutical company developing a focused portfolio of small molecules that modulate metabolic signaling pathways in the tumor microenvironment, today announced that Cancer Research UK, the world’s...
by andrewmm2007 | Oct 8, 2020 | Press Releases
San Francisco, CA / ACCESSWIRE / Oct 8, 2020 / Teon Therapeutics, Inc. has been invited to present at the Fall Private Company Showcase hosted by Solebury Trout, BMO and Davis Polk which is being held virtually on October 15, 2020. Teon is scheduled to present on...
